SCIENCE 37

News

 

Science 37 related announcements, media, stories, and more.

SCIENCE 37

News

 

Science 37 related announcements, media, stories, and more.

Our News
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
Science 37 Earns Frost & Sullivan’s 2024…
Top Honor Recognizes Science 37’s Visionary Innovation, Market-Leading Performance,…
/science-37-earns-frost-sullivans-2024-global-company-year-award-decentralized-clinical-trials
Our News
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
Science 37 Unveils New Corporate Headquarters in…
19,000-square-foot facility reflects the company’s recent growth and continued…
/science-37-unveils-new-corporate-headquarters-research-triangle-park-nc
Our News
Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
Science 37 Supports Phase 3 Clinical Trial with Recruitment and Enrollment,…
/science-37-enrolls-42-trial-cohort-8-weeks
Our News
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
Science 37 Quickly Impacts Performance in Under-…
Nearly 20 studies have successfully leveraged Science 37's medical and operational…
/science-37-quickly-impacts-performance-under-enrolling-clinical-trials
Our News
Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
Science 37 Surpasses Enrollment Goals,…
Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional…
/science-37-surpasses-enrollment-goals-accelerates-phase-2-rare-disease-clinical-trial
Blog
Evolution or Revolution?
Evolution or Revolution? How Clinical Trial…
How vital is clinical trial patient recruitment to the overall success of a clinical…
https://sc37-newdev.egroup-dev.com/evolution-or-revolution-how-clinical-trial-recruitment-moving-traditional-patient-referrals-fully
Our News
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
Science 37 Metasite™ Undergoes Successful FDA…
Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind…
/science-37-metasitetm-undergoes-successful-fda-inspection-marking-major-milestone-virtual-site
Our News
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
Science 37 Wins 2024 MedTech Breakthrough Award…
Science 37’s Patient Recruitment Recognized in Prestigious International Annual…
/science-37-wins-2024-medtech-breakthrough-award-clinical-efficiency-innovation
Our News
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
Science 37 Delivers 22x Faster Enrollment than…
Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x…
/science-37-delivers-22x-faster-enrollment-traditional-methods-phase-3-asthma-clinical-trial
Our News
Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
Science 37 Provides Fully Consented Patients to…
New patent-protected, central recruitment offering leverages the Science 37 Metasite…
/science-37-provides-fully-consented-patients-sites-supplement-enrollment
Our News
eMed Completes Tender Offer for All Outstanding Shares of Science 37
eMed Completes Tender Offer for All Outstanding…
MIAMI, March 12, 2024 /PRNewswire/ -- eMed, LLC ("eMed") today…
/emed-completes-tender-offer-all-outstanding-shares-science-37
News
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
Science 37 to be Acquired by eMed, Expanding…
Science 37 stockholders to receive $5.75 per share in cash

 

RESEARCH…
https://sc37-newdev.egroup-dev.com/science-37-be-acquired-emed-expanding-access-patients-and-accelerating-enrollment

© 2024  Science 37 | All Rights Reserved